-
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Author: Zhang, Chun-Ye; Liu, Shuai; Yang, Ming
Journal: WORLD JOURNAL OF HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 180-200. DOI: 10.4254/wjh.v15.i2.180
-
Current status and prospect of treatments for recurrent hepatocellular carcinoma
Author: Yang, Yu-Qing; Wen, Zhen-Yu; Liu, Xiao-Yan; Ma, Zhen-Hu; Liu, Yan-E; Cao, Xue-Ying; Hou, Li; Xie, Hui
Journal: WORLD JOURNAL OF HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 129-150. DOI: 10.4254/wjh.v15.i2.129
-
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
Author: Tan, You-Wen; Wang, Jia-Min; Zhou, Xing-Bei
Journal: WORLD JOURNAL OF HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 237-254. DOI: 10.4254/wjh.v15.i2.237
-
COVID-19 and liver dysfunction in children: Current views and new hypotheses
Author: Yun, Yang-Fang; Feng, Zhi-Yuan; Zhang, Jing-Jing
Journal: WORLD JOURNAL OF HEPATOLOGY. 2023; Vol. 15, Issue 3, pp. 353-363. DOI: 10.4254/wjh.v15.i3.353
-
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
Author: Ding, Jian; Xu, Chen; Xu, Ming; He, Xiao-Yue; Li, Wei-Na; He, Fei
Journal: WORLD JOURNAL OF HEPATOLOGY. 2023; Vol. 15, Issue 3, pp. 386-392. DOI: 10.4254/wjh.v15.i3.386